Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LUSI, $HBRM, $SAMP: Heating up
MHYS huge Sony news will still send this running
$DSCR: Qiaopai, New hemp food processor from China
$GEGP, $DKGR, $DBMM, $SRGL, $NOHO: 1s lotto
$DSCR: Building with Hempcrete
$DSCR: Chart & DD:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=109877969
- Go DSCR
$DSCR: Hemp oil extract CBD being promoted as alternative health treatment for cancer, epilepsy
ENRT CHANGING IT UP HERE......Hammer
"Times Have Changed So Have We" Enertopia Corp. (OTCBB: ENRT)
Enertopia Targets Canadian Medical Marijuana Business
$DSCR: Hemp oil extract CBD being promoted as alternative health treatment for cancer, epilepsy
$DSCR: Discovery Minerals Engages In Joint Venture Discussions with Florida Dispensary Candidate
Date : 05/06/2014 @ 8:30AM
Source : PR Newswire (US)
Stock : Discovery Minerals Ltd. (PC) (DSCR)
Discovery Minerals LTD. (OTC PINK: DSCR) (PINKSHEETS: DSCR) is currently in discussions with an established Florida nursery who meets the stringent application requirements of the recently passed Compassionate Medical Cannabis Act of 2014. In the event a license is granted, the dispensing organization will be responsible for the cultivation, processing, and dispensing of the low-THC Cannabis strain known as Charlotte's Web.
Announced May 1st, 2014, the newly passed Act in Florida requires certain specific criteria to qualify for the very limited number of available licenses; the nature of the requirements has reduced the number of possible applicants to approximately 35 entities. These applicants must be able to demonstrate a valid certificate of registration issued by Florida's Department of Agriculture and Consumer Services with 30 years of continuous operations. The full Act can be read by clicking this link:
www.flsenate.gov/Session/Bill/2014/1030/BillText/er/PDF
The potential Joint Venture between Discovery and the Nursery Partner will access a vertically integrated business network to conform to the law's proposed requirements.
About Discovery Minerals LTD.:
Discovery Minerals Ltd., (OTC: DSCR) is a production stage company formed to acquire and develop natural resource properties. Activities include gold, precious metals and petroleum minerals, including rare earth minerals production and sales. The Company initiated a new program to evaluate undervalued assets, including clean tech and alternative energy investments, for potential addition to its portfolio.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Contact Person:
Bill McNerney
+1-310-961-4654
At: info@discoveryholdingscorp.com
- Go DSCR
BABL NOW GOING GREEN.......5 days in a ROW......Hammer
BOY IS BABL GOING OFF ON THE SOCIAL MEDIA SITES......SEEN LIKE 40+++++++ TWEETS........Hammer
RVDO HERE.......GREAT NEWS LINKS....... http://www.otcmarkets.com/stock/RVDO/news - http://finance.yahoo.com/q/h?s=RVDO+Headlines
CLSN on fire!! check here -->
http://profit.ly/1MoBI4
Valeant Pharmaceuticals
One specialty pharmaceutical player that insiders are loading up on here is Valeant Pharmaceuticals (VRX), which develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. Insiders are buying this stock into massive strength, since shares are up sharply in 2013 by 86%.
>>4 Stocks Rising on Unusual Volume
Valeant Pharmaceuticals has a market cap of $37 billion and an enterprise value of $53 billion. This stock trades at a fair valuation, with a price-to-sales of 7.78 and a price-to-book of 7.35. This is not a cash-rich company, since the total cash position on its balance sheet is $596.35 million and its total debt is a whopping $17.40 billion.
The CEO just bought 184,247 shares, or about $14.99 million worth of stock, at $81.41 per share.
From a technical perspective, VRX is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock is starting to bounce higher right above its 50-day moving average of $108.87 a share. That bounce is quickly pushing shares of VRX within range of triggering a near-term breakout trade.
If you're bullish on VRX, then I would look for long-biased trades as long as this stock is trending above its 50-day at $108.87 or above more near-term support at $105.17 and then once breaks out above some near-term overhead resistance levels at $112.40 to $112.47 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.13 million shares. If that breakout hits soon, then VRX will set up to re-test or possibly take out its next major overhead resistance levels at $115 to its 52-week high at $115.40 a share. Any high-volume move above $115.40 will then give VRX a chance to tag of trend north of $120 a share.
Office Depot
Another name that insiders are very active in here is Office Depot (ODP), which is a global supplier of office products and services under the Office Depot brand and other proprietary brand names. Insiders are buying this stock into notable strength, since shares have risen 59% so far in 2013.
>>5 Rocket Stocks Worth Buying This Week
Office Depot has a market cap of $1.5 billion and an enterprise value of $1.2 billion. This stock trades at a fair valuation, with a trailing price-to-earnings of 43.78 and a forward price-to-earnings of 20.04. Its estimated growth rate for this year is -33.3%, and for next year it's pegged at 1,200%. This is a cash-rich company, since the total cash position on its balance sheet is $724.74 million and its total debt is $495.17 million.
A director just bought 1,350,000 shares, or about $7.04 million worth of stock, at $5.21 per share.
From a technical perspective, ODP is currently trending above its 200-day moving average and just below its 50-day moving average, which is neutral trendwise. This stock has been trending sideways for the last month and change, with shares moving between $4.83 on the downside and $5.85 on the upside. Traders should now look for any high-volume move above the upper-end of its recent range since that could trigger a big breakout trade for shares of ODP.
If you're in the bull camp on ODP, then I would look for long-biased trades as long as this stock is trending above some near-term support at $5.07 or above more support at $4.83 and then once it breaks out above some near-term overhead resistance levels at $5.65 to $5.85 a share, and then above its 52-week high at $6.10 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 11.07 million shares. If that breakout triggers soon, then ODP will set up to enter new 52-week-high territory above $6.10, which is bullish technical price action. Some possible upside targets off that move are $7 to $8 a share.
Horizon Pharma
One bio therapeutic drugs player that insiders are snapping up a large amount of stock in here is Horizon Pharma (HZNP) is a specialty pharmaceutical company that, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain and inflammatory diseases. Insiders are buying this stock into significant strength, since shares are up huge so far in 2013 by 192%.
>>5 Stocks Ready to Break Out
Horizon Pharma has a market cap of $448 million and an enterprise value of $434 million. This stock trades at a premium valuation, with a forward price-to-earnings of 84.25. Its estimated growth rate for this year is 62.4%, and for next year it's pegged at 109.4%. This is just barely a cash-rich company, since the total cash position on its balance sheet is $58.65 million and its total debt is $45.58 million.
A director just bought 668,673 shares, or about $4.34 million worth of stock, at $6.50 per share.
From a technical perspective, HZNP is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last three months and change, with shares moving higher from its low of $2.11 to its recent high of $7.39 a share. During that uptrend, shares of HZNP have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of HZNP within range of triggering a big breakout trade.
If you're bullish on HZNP, then I would look for long-biased trades as long as this stock is trending above some key near-term support levels at $6.64 or at $6, then once it breaks out above some near-term overhead resistance levels at $6.84 to $7.15 a share and then above its 52-week high at $7.39 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 1.27 million shares. If that breakout hits soon, then HZNP will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are its next major overhead resistance levels at $8.72 to $9. Any high-volume move above $9 will then give HZNP a chance to tag or trend north of $10 a share.
Nuance Communications
One technology player that insiders are jumping into large here is Nuance Communications (NUAN), which offers voice and language solutions for healthcare, mobile, consumer, enterprise customer service, and imaging markets. Insiders are buying this stock into significant weakness, since shares are down by 33%.
>>4 Tech Stocks Under $10 to Watch
Nuance Communications has a market cap of $4.6 billion and an enterprise value of $7.4 billion. This stock trades at a reasonable valuation, with a trailing price-to-earnings of 31.40 and a forward price-to-earnings of 10.29. Its estimated growth rate for this year is -18.8%, and for next year it's pegged at 12%. This is not a cash-rich company, since the total cash position on its balance sheet is $1.01 billion and its total debt is $2.34 billion.
A beneficial owner just bought 423,400 shares, or about $5.97 million worth of stock, at $14.12 to $14.20 per share.
From a technical perspective, NUAN is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been uptrending since gapping down sharply few weeks ago, with shares moving higher from its low of $13 to its intraday high of $14.93 a share. During that uptrend, shares of NUAN have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of NUAN within range of triggering a major breakout trade.
If you're bullish on NUAN, then I would look for long-biased trades as long as this stock is trending above some key near-term support levels at $14 or at $13.50, and then once it takes out its gap down day high of $14.91 a share high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 6.82 million shares. If that breakout hits soon, then NUAN will set up to re-fill some of its previous gap down zone that started near $16.50 a share. Any high-volume move above $16.50 will then give NUAN a chance to tag $18 to its 200-day moving average at $18.44 a share.
Esterline Technologies
One final name with some big insider buying is Esterline Technologies (ESL), which designs, manufactures and markets highly engineered products for the aerospace and defense sectors. Insiders are buying this stock into big time strength, since shares are up sharply by 51% so far in 2013.
>>The Truth About Amazon's Drones
Esterline Technologies has a market cap of $3 billion and an enterprise value of $3.2 billion. This stock trades at a reasonable valuation, with a trailing price-to-earnings of 18.84 and a forward price-to-earnings of 15.14. Its estimated growth rate for this year is -0.40%, and for next year it's pegged at 12.5%. This is not a cash-rich company, since the total cash position on its balance sheet is $199.25 million and its total debt is $754.49 million.
A director just bought 103,528 shares, or about $9.50 million worth of stock, at $91.55 to $92.51 per share.
From a technical perspective, ESL is currently trending well above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last two months, with shares soaring higher from its low of $78.17 to its intraday high of $96.81 a share.
During that uptrend, shares of ESL have been consistently making higher lows and higher highs, which is bullish technical price action. That said, shares of ESL have now started to enter overbought territory, since its current relative strength index reading is 79.91. Overbought can always get more overbought, but it's also an area that can be dangerous to enter a stock from the long side.
If you're bullish on ESL, then I would look to get long this strong trending stock after it works off some of its current overbought condition. Look for a sharp pullback in shares of ESL that bring the stock down towards some key near-term support levels around the $87.50 area, or near its 50-day moving average of $83.78 a share. If ESL doesn't pullback significantly, then traders can look to go long this stock once it clears and closes above its new 52-week high at $96.81 a share with strong volume.
To see more stocks with notable insider buying, check out the Stocks With Big Insider Buying portfolio on
Max Keiser Discusses QE & Rigged Global Markets -
30 Min. says TCEL BOUNCE IS COMING........Hammer
FNRC NEWS LINK.....Hammer
http://ih.advfn.com/p.php?pid=nmona&article=54769546
CAHI and SNTL are 2 solid plays that I am accumulating.
I have DD sheets for Madison Square Garden (big board)
and for APDN my favorite, a pink. What would you guys like.
tomorrow.
Baggers thanks you
Hi Cube. Looking in. B'marked.
VNDB setting up for a bounce imo.
Thanks Baggers...will take a look.
Marked the board.
AUMN shareholder fact sheet shows 60M ounces of silver, and an additional 60M ounces found in an infrared scan. Total of 120M ounces of Silver which = 3.4B. Current Market Cap = $261M.
http://www.goldenminerals.com/pdfs/GLDN_InvestorKit/Golden-Minerals-Fact-Sheet-Sept-2012.pdf